AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNTB
  4. [8-K] Connect Biopharma Holdings Limited American Reports Material Event

[8-K] Connect Biopharma Holdings Limited American Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source:

Stock CNTB logo
Connect Biopharma Holdings Ltd

NASDAQ:CNTB

CNTB Rankings

#7795 Ranked by Market Cap
N/A Ranked by Dividends
#122 Top Gainer

CNTB Latest News

Jul 18, 2025
Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference
Jul 17, 2025
Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Jul 9, 2025
Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China
Jun 13, 2025
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
Jun 3, 2025
Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

CNTB Latest SEC Filings

Jul 9, 2025
[8-K] Connect Biopharma Holdings Limited American Reports Material Event
Jun 27, 2025
[EFFECT] Connect Biopharma Holdings Limited American SEC Filing

CNTB Stock Data

63.90M
32.97M
41.16%
44.85%
0.08%
Biotechnology
Pharmaceutical Preparations
United States
SAN DIEGO